Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 405

1.

Outcomes of de novo allograft diabetic nephropathy in renal allograft recipients.

Prasad N, Gupta P, Jain M, Bhadauria D, Gupta A, Sharma RK, Kaul A.

Exp Clin Transplant. 2013 Jun;11(3):215-21.

2.

Allograft diabetic nephropathy may progress to end-stage renal disease.

Salifu MO, Nicastri AD, Markell MS, Ghali H, Sommer BG, Friedman EA.

Pediatr Transplant. 2004 Aug;8(4):351-6.

PMID:
15265161
3.

Diabetic nephropathy after renal transplantation. Clinical and pathologic features.

Hariharan S, Smith RD, Viero R, First MR.

Transplantation. 1996 Sep 15;62(5):632-5.

PMID:
8830828
4.

De novo diabetic nephropathy with functional impairment in a renal allograft.

Gimenez LF, Watson AJ, Burrow CR, Olson JL, Klassen DK, Cooke CR.

Am J Nephrol. 1986;6(5):378-81.

PMID:
3548353
5.

Rapid onset of diabetic nephropathy in three renal allografts despite normoglycemia.

Wojciechowski D, Onozato ML, Gonin J.

Clin Nephrol. 2009 Jun;71(6):719-24.

PMID:
19473643
6.

Chronic allograft nephropathy or interstitial fibrosis and tubular atrophy: what is in a name?

Haas M.

Curr Opin Nephrol Hypertens. 2014 May;23(3):245-50. doi: 10.1097/01.mnh.0000444811.26884.2d. Review.

PMID:
24626060
7.
8.

Renal dysfunction and intragraft proMMP9 activity in renal transplant recipients with interstitial fibrosis and tubular atrophy.

Racca MA, Novoa PA, Rodríguez I, Della Vedova AB, Pellizas CG, Demarchi M, Donadio AC.

Transpl Int. 2015 Jan;28(1):71-8. doi: 10.1111/tri.12445. Epub 2014 Oct 2.

9.

Low prevalence of BK virus nephropathy on nonprotocol renal biopsies in Iranian kidney transplant recipients: one center's experience and review of the literature.

Soleymanian T, Rasulzadegan MH, Sotoodeh M, Ganji MR, Naderi G, Amin M, Saddadi F, Hakemi M, Najafi I.

Exp Clin Transplant. 2010 Dec;8(4):297-302. Review.

10.

The natural history of chronic allograft nephropathy.

Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR.

N Engl J Med. 2003 Dec 11;349(24):2326-33.

11.

Risk factors and outcomes of new-onset diabetes after transplant: single-centre experience.

Al-Ghareeb SM, El-Agroudy AE, Al Arrayed SM, Al Arrayed A, Alhellow HA.

Exp Clin Transplant. 2012 Oct;10(5):458-65. doi: 10.6002/ect.2012.0063. Epub 2012 Aug 29.

12.
13.

Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR).

Hariharan S, Adams MB, Brennan DC, Davis CL, First MR, Johnson CP, Ouseph R, Peddi VR, Pelz CJ, Roza AM, Vincenti F, George V.

Transplantation. 1999 Sep 15;68(5):635-41.

PMID:
10507481
14.

Functional and histopathologic changes in renal transplant patients with new-onset diabetes and dyslipidemia.

Borda B, Szederkényi E, Lengyel C, Morvay Z, Eller J, Marofka F, Szabó V, Takács T, Szenohradszky P, Hódi Z, Lázár G.

Transplant Proc. 2011 May;43(4):1254-8. doi: 10.1016/j.transproceed.2011.03.091.

PMID:
21620104
15.

The histology of kidney transplant failure: a long-term follow-up study.

Naesens M, Kuypers DR, De Vusser K, Evenepoel P, Claes K, Bammens B, Meijers B, Sprangers B, Pirenne J, Monbaliu D, Jochmans I, Lerut E.

Transplantation. 2014 Aug 27;98(4):427-35. doi: 10.1097/TP.0000000000000183.

PMID:
25243513
16.

Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction.

Khalkhali HR, Ghafari A, Hajizadeh E, Kazemnejad A.

Exp Clin Transplant. 2010 Dec;8(4):277-82.

17.

De novo diabetic glomerulosclerosis in a renal allograft recipient.

Sharma UK, Jha V, Gupta KL, Joshi K, Sakhuja V.

Am J Kidney Dis. 1994 Apr;23(4):597-9.

PMID:
8154499
18.

Peripheral vascular disease after kidney-pancreas transplantation in diabetic patients with end-stage renal disease.

Morrissey PE, Shaffer D, Monaco AP, Conway P, Madras PN.

Arch Surg. 1997 Apr;132(4):358-61; discussion 361-2.

PMID:
9108755
19.

Early epithelial phenotypic changes predict graft fibrosis.

Hertig A, Anglicheau D, Verine J, Pallet N, Touzot M, Ancel PY, Mesnard L, Brousse N, Baugey E, Glotz D, Legendre C, Rondeau E, Xu-Dubois YC.

J Am Soc Nephrol. 2008 Aug;19(8):1584-91. doi: 10.1681/ASN.2007101160. Epub 2008 Apr 23.

20.

Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.

Uslu A, Nart A, Taşli FA, Postaci H, Aykas A, Doğan M, Sahin T.

Nephrology (Carlton). 2008 Feb;13(1):80-6. doi: 10.1111/j.1440-1797.2007.00866.x.

PMID:
18199109

Supplemental Content

Support Center